Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Angiogenesis in patients with hematologic malignancies].

R M Mesters1, T Padró, M Steins

  • 1Medizinische Klinik und Poliklinik A, Universitätsklinikum Münster, Germany. mesters@uni-muenster.de

Onkologie
|October 16, 2001
PubMed
Summary

Thalidomide demonstrates anti-angiogenic and anti-leukemic effects in acute myeloid leukemia (AML) patients, reducing bone marrow microvessel density. This suggests targeting angiogenesis is a promising strategy for hematologic malignancies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical outcomes of drug-coated balloon vs. second-generation drug-eluting stent for coronary in-stent restenosis.

Clinical research in cardiology : official journal of the German Cardiac Society·2025
Same author

SVEP1 influences monocyte to macrophage differentiation via integrin α4β1/α9β1 and Rho/Rac signalling.

Biochimica et biophysica acta. Molecular cell research·2023
Same author

Improvement of functional outcome for patients with newly diagnosed grade 2 or 3 gliomas with co-deletion of 1p/19q - IMPROVE CODEL: the NOA-18 trial.

BMC cancer·2022
Same author

Magnetization transfer ratio: a quantitative imaging biomarker for 5q spinal muscular atrophy.

European journal of neurology·2020
Same author

Effect of Linearization in a WNT Signaling Model.

Computational and mathematical methods in medicine·2019
Same author

Circulating microparticles are associated with clinical severity of persistent ST-segment elevation myocardial infarction complicated with cardiogenic shock.

International journal of cardiology·2018

Area of Science:

  • Hematologic Oncology
  • Tumor Angiogenesis
  • Molecular Biology

Context:

  • Angiogenesis is crucial for solid tumor growth and increasingly implicated in hematologic malignancies.
  • Increased bone marrow angiogenesis observed in acute myeloid leukemia (AML) patients, normalizing with remission.
  • Key mediators like VEGF and FGF drive tumor neovascularization.

Purpose:

  • To investigate the role of angiogenesis and its mediators in hematologic malignancies.
  • To evaluate the anti-angiogenic and anti-leukemic effects of thalidomide in AML.
  • To explore the therapeutic potential of targeting the VEGF/VEGFR-2 pathway.

Summary:

  • Thalidomide exhibits anti-angiogenic activity, decreasing microvessel density in AML patients.
  • Thalidomide showed anti-leukemic effects, with partial responses observed in a phase I/II study.

Related Experiment Videos

  • The VEGF/VEGFR-2 pathway is implicated in AML growth, suggesting it as a therapeutic target.

    • Impact:

    • Thalidomide shows promise as an anti-angiogenic and anti-leukemic agent in AML.
    • Targeting angiogenesis represents a potential therapeutic strategy for hematologic malignancies.
    • Further research into receptor tyrosine kinase inhibitors is warranted for AML treatment.